|
Symbol
|
PMWLTQ | Z093XZ | OCJRCH | IHTEFG | HZJEFG | RMBFAV | OOIRCH | RLOALV | Z09YGZ | PBURCH | RMA3QV | RMBRKV | ERORCH | PEIRCH | ABMUTQ | PJIRCH | AZFBIL | PRZRCH | Z0ARNZ | CQWBKB |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Multi Reverse Convertible | Autocallable Reverse Convertible Defensive worst | Worst of Callable Reverse Convertible | Reverse Convertible | Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Reverse Convertible | Autocallable Reverse Convertible Defensive worst | Worst of Callable Reverse Convertible | Multi Vonti | Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Reverse Convertible | Worst of Callable Reverse Convertible | Reverse Convertible | Worst of Callable Reverse Convertible | Autocallable Reverse Convertible Defensive worst | Reverse Convertible |
|
Basiswert
|
Amgen Inc. / Lonza Group N / Novartis Sandoz Basket / Pfizer Inc. / Roche AG | Lonza Group N / Tecan Group AG / Ypsomed Hldg. AG | Kühne & Nagel Intl. AG / Lonza Group N / Sandoz Group AG | Compagnie Financière Richemont SA / Lonza Group N / Sonova Hldg. AG / Swiss RE AG / Swisscom N | Lonza Group N / Roche GS / Sika AG | Kühne & Nagel Intl. AG / Lonza Group N / Sika AG | Holcim/Amrize Basket / Kühne & Nagel Intl. AG / Lonza Group N / VAT Group | Lonza Group N | Compagnie Financière Richemont SA / Lonza Group N / Schindler PS / Sika AG | Alcon / Lonza Group N / Sandoz Group AG | Alcon / Lonza Group N / Novartis AG / Roche AG / Sandoz Group AG | Bucher Industries AG / Lonza Group N / Sika AG | BKW AG / Kühne & Nagel Intl. AG / Lonza Group N | Lonza Group N / Novartis AG / Roche AG / Sandoz | Clariant AG / Comet Hldg. AG / Lonza Group N / OC Oerlikon N / Swatch Group I | Bachem Hldg. AG / Lonza Group N / Ypsomed Hldg. AG | Companie Financière Richemont SA / Julius Baer Group / Lonza Group N | Lonza Group N / Swiss Life Hldg. N / Swiss RE AG | Holcim/Amrize Basket / Lonza Group N / Sandoz Group AG | Lonza Group N / Novartis N / Roche GS / Straumann Hldg. AG |
|
Emittent
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fälligkeit
|
09.02.2026 | 19.02.2026 | 08.04.2026 | 28.06.2029 | 02.11.2026 | 13.07.2026 | 15.01.2026 | 30.12.2025 | 27.08.2027 | 21.07.2026 | 09.11.2026 | 05.11.2026 | 06.11.2026 | 11.11.2026 | 20.12.2029 | 16.06.2026 | 04.02.2026 | 24.02.2027 | 25.08.2026 | 13.03.2028 |
| Ratio | - | - | - | - | - | - | - | 0,09944 | - | - | - | - | - | - | - | - | - | - | - | - |
|
Ausübungs-Preis
|
218.09 | 357.44 | 20.8837 | 325.00 | 182.298 | 214.60 | 171.665 | 497.20 | 386.538 | 26.509 | 384.30 | 197.80 | 141.44 | 28.077 | 171.275 | 349.874 | 129.4125 | 416.78 | 33.0638 | 378.0225 |
|
Maximal- rendite p.a. |
- | 634.35% | 39.73% | - | - | 64.12% | 14.18% | - | 14.08% | 7.84% | 7.67% | 28.23% | 5.62% | 4.60% | 13.21% | 8.14% | -0.08% | 5.53% | 6.55% | 7.24% |
| Geld | 95.72 | 48.170 | - | - | 86.65 | 77.10 | 99.50 | 99.70 | - | - | 97.60 | 91.90 | - | 99.58 | 77.32 | 97.74 | 101.11 | 97.73 | - | 94.98 |
| Brief | - | 49.070 | - | - | - | 77.90 | 100.30 | 100.30 | - | - | 98.40 | 92.70 | - | 100.38 | 78.10 | 98.54 | 101.92 | 98.53 | - | 95.78 |